Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 1.42
MDSO's Cash-to-Debt is ranked lower than
67% of the 1722 Companies
in the Global Health Information Services industry.

( Industry Median: 9.76 vs. MDSO: 1.42 )
Ranked among companies with meaningful Cash-to-Debt only.
MDSO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.4  Med: 1.42 Max: No Debt
Current: 1.42
Equity-to-Asset 0.49
MDSO's Equity-to-Asset is ranked lower than
65% of the 1625 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. MDSO: 0.49 )
Ranked among companies with meaningful Equity-to-Asset only.
MDSO' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.75  Med: 0.4 Max: 0.63
Current: 0.49
-1.75
0.63
Interest Coverage 2.90
MDSO's Interest Coverage is ranked lower than
91% of the 1649 Companies
in the Global Health Information Services industry.

( Industry Median: 152.54 vs. MDSO: 2.90 )
Ranked among companies with meaningful Interest Coverage only.
MDSO' s Interest Coverage Range Over the Past 10 Years
Min: 1.31  Med: 4.38 Max: 202.12
Current: 2.9
1.31
202.12
Piotroski F-Score: 7
Altman Z-Score: 6.35
Beneish M-Score: -2.62
WACC vs ROIC
14.02%
15.33%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 10.84
MDSO's Operating Margin % is ranked higher than
71% of the 1662 Companies
in the Global Health Information Services industry.

( Industry Median: 4.45 vs. MDSO: 10.84 )
Ranked among companies with meaningful Operating Margin % only.
MDSO' s Operating Margin % Range Over the Past 10 Years
Min: -36.17  Med: 8.04 Max: 14
Current: 10.84
-36.17
14
Net Margin % 6.25
MDSO's Net Margin % is ranked higher than
63% of the 1663 Companies
in the Global Health Information Services industry.

( Industry Median: 2.83 vs. MDSO: 6.25 )
Ranked among companies with meaningful Net Margin % only.
MDSO' s Net Margin % Range Over the Past 10 Years
Min: -37.57  Med: 4.86 Max: 21.36
Current: 6.25
-37.57
21.36
ROE % 8.66
MDSO's ROE % is ranked higher than
59% of the 1603 Companies
in the Global Health Information Services industry.

( Industry Median: 5.49 vs. MDSO: 8.66 )
Ranked among companies with meaningful ROE % only.
MDSO' s ROE % Range Over the Past 10 Years
Min: 2.48  Med: 9.06 Max: 63.95
Current: 8.66
2.48
63.95
ROA % 3.94
MDSO's ROA % is ranked higher than
57% of the 1727 Companies
in the Global Health Information Services industry.

( Industry Median: 2.51 vs. MDSO: 3.94 )
Ranked among companies with meaningful ROA % only.
MDSO' s ROA % Range Over the Past 10 Years
Min: -106.4  Med: 4.02 Max: 22.66
Current: 3.94
-106.4
22.66
ROC (Joel Greenblatt) % 91.43
MDSO's ROC (Joel Greenblatt) % is ranked higher than
74% of the 1681 Companies
in the Global Health Information Services industry.

( Industry Median: 21.53 vs. MDSO: 91.43 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MDSO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -318.3  Med: 80.74 Max: 277.92
Current: 91.43
-318.3
277.92
3-Year Revenue Growth Rate 16.50
MDSO's 3-Year Revenue Growth Rate is ranked higher than
80% of the 1436 Companies
in the Global Health Information Services industry.

( Industry Median: 5.00 vs. MDSO: 16.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MDSO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -21.7  Med: 11.05 Max: 17.5
Current: 16.5
-21.7
17.5
3-Year EBITDA Growth Rate 28.40
MDSO's 3-Year EBITDA Growth Rate is ranked higher than
80% of the 1197 Companies
in the Global Health Information Services industry.

( Industry Median: 7.90 vs. MDSO: 28.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MDSO' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -0.05 Max: 28.4
Current: 28.4
0
28.4
3-Year EPS without NRI Growth Rate 18.10
MDSO's 3-Year EPS without NRI Growth Rate is ranked higher than
66% of the 1081 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. MDSO: 18.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MDSO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -48.4  Med: -13.1 Max: 40.9
Current: 18.1
-48.4
40.9
GuruFocus has detected 4 Warning Signs with Medidata Solutions Inc $MDSO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MDSO's 10-Y Financials

Financials (Next Earnings Date: 2017-05-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MDSO Guru Trades in Q1 2016

Chuck Royce 188,165 sh (+20.88%)
Columbia Wanger 1,864,018 sh (+0.15%)
Frank Sands 4,140,933 sh (-24.24%)
» More
Q2 2016

MDSO Guru Trades in Q2 2016

Joel Greenblatt 8,271 sh (New)
Chuck Royce 188,165 sh (unchged)
Frank Sands 4,002,133 sh (-3.35%)
Columbia Wanger 1,729,046 sh (-7.24%)
» More
Q3 2016

MDSO Guru Trades in Q3 2016

Paul Tudor Jones 6,643 sh (New)
Chuck Royce 188,165 sh (unchged)
Joel Greenblatt Sold Out
Frank Sands 3,862,933 sh (-3.48%)
Columbia Wanger 851,182 sh (-50.77%)
» More
Q4 2016

MDSO Guru Trades in Q4 2016

Jim Simons 59,894 sh (New)
Chuck Royce 188,165 sh (unchged)
Paul Tudor Jones Sold Out
Frank Sands 3,788,033 sh (-1.94%)
Columbia Wanger 795,140 sh (-6.58%)
» More
» Details

Insider Trades

Latest Guru Trades with MDSO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 511210    SIC: 7372
Compare: » details
Traded in other countries:2M9.Germany,
Medidata Solutions Inc provides cloud-based solutions for life sciences. It offers products and services including Medidata Rave, Medidata CTMS, Medidata Designer, Medidata Insights, and Medidata Grants Manager.

Medidata provides cloud-based solutions for the clinical development programs of life sciences companies. Its customers include biopharmaceutical companies, device makers, contract research organizations, and academic institutions. The majority of the company's business comes from subscriptions to the Medidata Clinical Cloud, with the remainder of revenue coming from services. The Medidata Clinical Cloud provides solutions for study design and planning, data capture, patient activity measurement, risk-based monitoring, and payments. The services segment includes technology and support services and professional consulting services. The majority of the firm's revenue is generated within the United States.

Top Ranked Articles about Medidata Solutions Inc

Columbia Wanger's Largest Trades in 3rd Quarter The guru's most significant transactions
Columbia funds are managed by Columbia Management Investment Advisers LLC, and Columbia Acorn funds are managed by Columbia Wanger (Trades, Portfolio) Asset Management LLC, a subsidiary of Columbia Management Investment Advisers, LLC. During the third quarter the guru’s largest trades were the following: Read more...

Ratios

vs
industry
vs
history
PE Ratio 110.37
MDSO's PE Ratio is ranked lower than
89% of the 1570 Companies
in the Global Health Information Services industry.

( Industry Median: 24.77 vs. MDSO: 110.37 )
Ranked among companies with meaningful PE Ratio only.
MDSO' s PE Ratio Range Over the Past 10 Years
Min: 11.29  Med: 102.28 Max: 2129.13
Current: 110.37
11.29
2129.13
Forward PE Ratio 45.45
MDSO's Forward PE Ratio is ranked lower than
78% of the 382 Companies
in the Global Health Information Services industry.

( Industry Median: 22.27 vs. MDSO: 45.45 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 110.37
MDSO's PE Ratio without NRI is ranked lower than
89% of the 1364 Companies
in the Global Health Information Services industry.

( Industry Median: 26.00 vs. MDSO: 110.37 )
Ranked among companies with meaningful PE Ratio without NRI only.
MDSO' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.06  Med: 102.28 Max: 2129.13
Current: 110.37
11.06
2129.13
Price-to-Owner-Earnings 264.19
MDSO's Price-to-Owner-Earnings is ranked lower than
95% of the 757 Companies
in the Global Health Information Services industry.

( Industry Median: 24.01 vs. MDSO: 264.19 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MDSO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 28.78  Med: 178.16 Max: 10780
Current: 264.19
28.78
10780
PB Ratio 8.09
MDSO's PB Ratio is ranked lower than
80% of the 2019 Companies
in the Global Health Information Services industry.

( Industry Median: 2.94 vs. MDSO: 8.09 )
Ranked among companies with meaningful PB Ratio only.
MDSO' s PB Ratio Range Over the Past 10 Years
Min: 4.53  Med: 9.6 Max: 29.12
Current: 8.09
4.53
29.12
PS Ratio 6.96
MDSO's PS Ratio is ranked lower than
82% of the 2019 Companies
in the Global Health Information Services industry.

( Industry Median: 2.35 vs. MDSO: 6.96 )
Ranked among companies with meaningful PS Ratio only.
MDSO' s PS Ratio Range Over the Past 10 Years
Min: 1.29  Med: 5.76 Max: 12.47
Current: 6.96
1.29
12.47
Price-to-Free-Cash-Flow 50.89
MDSO's Price-to-Free-Cash-Flow is ranked lower than
77% of the 841 Companies
in the Global Health Information Services industry.

( Industry Median: 25.65 vs. MDSO: 50.89 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MDSO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.98  Med: 45.24 Max: 274.73
Current: 50.89
12.98
274.73
Price-to-Operating-Cash-Flow 36.10
MDSO's Price-to-Operating-Cash-Flow is ranked lower than
77% of the 1054 Companies
in the Global Health Information Services industry.

( Industry Median: 18.79 vs. MDSO: 36.10 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MDSO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.19  Med: 35.05 Max: 136.33
Current: 36.1
10.19
136.33
EV-to-EBIT 57.48
MDSO's EV-to-EBIT is ranked lower than
87% of the 1621 Companies
in the Global Health Information Services industry.

( Industry Median: 16.27 vs. MDSO: 57.48 )
Ranked among companies with meaningful EV-to-EBIT only.
MDSO' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.7  Med: 53.45 Max: 344.6
Current: 57.48
8.7
344.6
EV-to-EBITDA 44.86
MDSO's EV-to-EBITDA is ranked lower than
86% of the 1758 Companies
in the Global Health Information Services industry.

( Industry Median: 12.93 vs. MDSO: 44.86 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDSO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.8  Med: 38.8 Max: 133.6
Current: 44.86
6.8
133.6
PEG Ratio 10.61
MDSO's PEG Ratio is ranked lower than
89% of the 561 Companies
in the Global Health Information Services industry.

( Industry Median: 1.97 vs. MDSO: 10.61 )
Ranked among companies with meaningful PEG Ratio only.
MDSO' s PEG Ratio Range Over the Past 10 Years
Min: 8.16  Med: 22.6 Max: 240.84
Current: 10.61
8.16
240.84
Current Ratio 3.92
MDSO's Current Ratio is ranked higher than
81% of the 1546 Companies
in the Global Health Information Services industry.

( Industry Median: 1.83 vs. MDSO: 3.92 )
Ranked among companies with meaningful Current Ratio only.
MDSO' s Current Ratio Range Over the Past 10 Years
Min: 0.44  Med: 2.27 Max: 3.92
Current: 3.92
0.44
3.92
Quick Ratio 3.92
MDSO's Quick Ratio is ranked higher than
82% of the 1546 Companies
in the Global Health Information Services industry.

( Industry Median: 1.72 vs. MDSO: 3.92 )
Ranked among companies with meaningful Quick Ratio only.
MDSO' s Quick Ratio Range Over the Past 10 Years
Min: 0.44  Med: 2.27 Max: 3.92
Current: 3.92
0.44
3.92
Days Sales Outstanding 90.75
MDSO's Days Sales Outstanding is ranked lower than
69% of the 1319 Companies
in the Global Health Information Services industry.

( Industry Median: 68.13 vs. MDSO: 90.75 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDSO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 45.45  Med: 74.88 Max: 90.9
Current: 90.75
45.45
90.9
Days Payable 20.10
MDSO's Days Payable is ranked lower than
74% of the 1176 Companies
in the Global Health Information Services industry.

( Industry Median: 41.35 vs. MDSO: 20.10 )
Ranked among companies with meaningful Days Payable only.
MDSO' s Days Payable Range Over the Past 10 Years
Min: 16.07  Med: 23.22 Max: 54.1
Current: 20.1
16.07
54.1

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -2.50
MDSO's 3-Year Average Share Buyback Ratio is ranked lower than
51% of the 1136 Companies
in the Global Health Information Services industry.

( Industry Median: -2.40 vs. MDSO: -2.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MDSO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -55.7  Med: -4 Max: -2.5
Current: -2.5
-55.7
-2.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 31.62
MDSO's Price-to-Net-Current-Asset-Value is ranked lower than
89% of the 1370 Companies
in the Global Health Information Services industry.

( Industry Median: 7.03 vs. MDSO: 31.62 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
MDSO' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 8.77  Med: 22.11 Max: 4775
Current: 31.62
8.77
4775
Price-to-Tangible-Book 8.88
MDSO's Price-to-Tangible-Book is ranked lower than
70% of the 1669 Companies
in the Global Health Information Services industry.

( Industry Median: 4.31 vs. MDSO: 8.88 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MDSO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.33  Med: 10.58 Max: 59.17
Current: 8.88
6.33
59.17
Price-to-Intrinsic-Value-Projected-FCF 3.38
MDSO's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
70% of the 1056 Companies
in the Global Health Information Services industry.

( Industry Median: 2.02 vs. MDSO: 3.38 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MDSO' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 2.98  Med: 4.84 Max: 9.77
Current: 3.38
2.98
9.77
Price-to-Median-PS-Value 1.20
MDSO's Price-to-Median-PS-Value is ranked lower than
54% of the 1789 Companies
in the Global Health Information Services industry.

( Industry Median: 1.16 vs. MDSO: 1.20 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MDSO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.38  Med: 0.93 Max: 2.03
Current: 1.2
0.38
2.03
Price-to-Peter-Lynch-Fair-Value 12.32
MDSO's Price-to-Peter-Lynch-Fair-Value is ranked lower than
97% of the 435 Companies
in the Global Health Information Services industry.

( Industry Median: 1.55 vs. MDSO: 12.32 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MDSO' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 9.22  Med: 10.05 Max: 12.7
Current: 12.32
9.22
12.7
Price-to-Graham-Number 6.60
MDSO's Price-to-Graham-Number is ranked lower than
87% of the 1021 Companies
in the Global Health Information Services industry.

( Industry Median: 2.20 vs. MDSO: 6.60 )
Ranked among companies with meaningful Price-to-Graham-Number only.
MDSO' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.96  Med: 7.91 Max: 14.34
Current: 6.6
1.96
14.34
Earnings Yield (Greenblatt) % 1.78
MDSO's Earnings Yield (Greenblatt) % is ranked lower than
56% of the 2417 Companies
in the Global Health Information Services industry.

( Industry Median: 2.96 vs. MDSO: 1.78 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MDSO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.3  Med: 1.9 Max: 11.5
Current: 1.78
0.3
11.5
Forward Rate of Return (Yacktman) % 10.33
MDSO's Forward Rate of Return (Yacktman) % is ranked higher than
50% of the 771 Companies
in the Global Health Information Services industry.

( Industry Median: 10.49 vs. MDSO: 10.33 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MDSO' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -3.1  Med: 1 Max: 21.2
Current: 10.33
-3.1
21.2

More Statistics

Revenue (TTM) (Mil) $463.4
EPS (TTM) $ 0.51
Beta1.62
Short Percentage of Float11.01%
52-Week Range $35.59 - 58.77
Shares Outstanding (Mil)57.71

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 553 640
EPS ($) 1.23 1.50
EPS without NRI ($) 1.23 1.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for MDSO

Headlines

Articles On GuruFocus.com
Trump's New Health Care Frontier Mar 14 2017 
These Stocks Are More Than You Think Nov 21 2016 
Columbia Wanger's Largest Trades in 3rd Quarter Nov 11 2016 
There’s More In The Clouds At Medidata Than Just The Valuation Jul 21 2015 
Frank Sands Adds to His Position in Medidata Solutions, Inc. Jul 14 2015 
Medidata: SaaS Business Model Leveraging Growth Of The Company Oct 23 2014 
Frank Sands Adds 5 New Stocks Aug 14 2014 
Medidata Solutions: Benefit from Growing Cloud Applications with This Stock May 27 2014 
Medidata Solutions : A SAAS Provider For Your Portfolio Mar 23 2014 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,667 Shares Mar 08 2011 

More From Other Websites
Medidata Clinical Cloud Selected for AML Master Trial by LLS Mar 24 2017
Medidata’s Clinical Technology Platform Selected for Groundbreaking “Beat AML Master Trial” Mar 23 2017
Trump's New Health Care Frontier Mar 14 2017
MEDIDATA SOLUTIONS, INC. Financials Mar 04 2017
Medidata and INC Research Expand Technology Partnership Mar 02 2017
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Mar 01 2017
MEDIDATA SOLUTIONS, INC. Files SEC form 10-K, Annual Report Feb 28 2017
Medidata and Medical Device Innovation Consortium Partner to Help Drive Change in the Medical... Feb 28 2017
Digirad Corporation (DRAD) Looks Good: Stock Jumps 10% Feb 27 2017
Medidata to Present at Upcoming Investor Conferences Feb 22 2017
Why Medidata Solutions (MDSO) Could Be an Impressive Growth Stock Feb 16 2017
Will Medidata Solutions (MDSO) Continue to Surge Higher? Feb 15 2017
Medidata Solutions, Inc. :MDSO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 13, 2017 Feb 13 2017
Medidata Solutions, Inc. :MDSO-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017 Feb 10 2017
Medidata Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDSO-US : February... Feb 10 2017
Edited Transcript of MDSO earnings conference call or presentation 9-Feb-17 1:00pm GMT Feb 09 2017
Q4 2016 Medidata Solutions Inc Earnings Release - Before Market Open Feb 09 2017
Medidata tops Street 4Q forecasts Feb 09 2017
Medidata tops Street 4Q forecasts Feb 09 2017
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 09 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)